Cannabis-Based Medicines in Gastroparesis and Related Syndromes – AtlantiCare
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic…
Why Some Heavy Cannabis Users Can’t Stop Throwing Up, According to New Research
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Cannabinoid HyperemesisHeavy…
Delta-9-Tetrahydrocannabinol alleviates doxorubicin-induced weight loss but does not affect dextran sodium sulphate-induced colitis.
Gastrointestinal mucositis is a common adverse effect of chemotherapy. Inflammatory bowel diseases (IBD) are a spectrum of chronic inflammatory disorders of ...
Australian Trial to Test Medicinal Cannabis Against Chemotherapy’s Gut Side Effects
"There are currently no effective approved interventions to prevent gastrointestinal symptom clusters in people undergoing cytotoxic cancer therapy."
The dual roles of natural cannabidiol in combating oxidative stress and inflammation: A potential intestinal guardian.
Cannabidiol (CBD), a non-psychoactive and non-addictive phytocannabinoid derived from Cannabis sativa L., has attracted increasing attention for its therapeu...